百奥赛图-B2023 中期报告

Interim Report中期報告Stock code 股份代號：2315百奧賽圖北京醫藥科技股份有限公司Biocytogen Pharmaceuticals (Beijing) Co., Ltd.(A joint stock company incorporated in the People’s Republic of China with limited liability)（於中華人民共和國註冊成立的股份有限公司）2023 11百奧賽圖(北京)醫藥科技股份有限公司 二零二三年中期報告目錄 Contents公司資料2Corporate Information財務概要6Financial Summary管理層討論與分析7Management Discussion and Analysis企業管治及其他資料51Corporate Governance and Other Information審閱報告75Review Report綜合損益及其他全面收入表77Consolidated Statements of Profit or Loss and Other Comprehensive Income綜合財務狀況表78Consolidated Statements of Financial Position綜合權益變動表80Consolidated Statements of Changes in Equity簡明綜合現金流量表81Condensed Consolidated Cash Flows Statements未經審核中期財務報告附註82Notes to the Unaudited Interim Financial Report釋義107Definition 2Biocytogen Pharmaceuticals (Beijing) Co., Ltd. Interim Report 2023公司資料Corporate InformationCHINESE NAME百奧賽圖(北京)醫藥科技股份有限公司ENGLISH NAMEBiocytogen Pharmaceuticals (Beijing) Co., Ltd.*STOCK CODE02315LEGAL REPRESENTATIVEDr. Shen YueleiCHAIRMAN OF THE BOARDDr. Shen YueleiHEAD OFFICE AND PRINCIPLE PLACE OF BUSINESS IN CHINA12 Baoshen South StreetDaxing Bio-Medicine Industry ParkDaxing District, BeijingPRCREGISTERED OFFICE12 Baoshen South StreetDaxing Bio-Medicine Industry ParkDaxing District, BeijingPRCPRINCIPAL PLACE OF BUSINESS IN HONG KONG40th Floor, Dah Sing Financial CenterNo. 248 Queen’s Road EastWanchaiHong Kong* For identification purpose only中文名稱百奧賽圖（北京）醫藥科技股份有限公司英文名稱Biocytogen Pharmaceuticals (Beijing) Co., Ltd.*股份代號02315法定代表人沈月雷博士董事長沈月雷博士總辦事處及中國主要營業地點中國北京市大興區大興生物醫藥產業基地寶參南街12號院註冊辦事處中國北京市大興區大興生物醫藥產業基地寶參南街12號院香港主要營業地點香港灣仔皇后大道東248號大新金融中心40樓* 僅供識別 33百奧賽圖(北京)醫藥科技股份有限公司 二零二三年中期報告公司資料Corporate Information董事會執行董事沈月雷博士（董事長、首席執行官兼總經理）倪健博士張海超博士（動物中心高級運營總監）非執行董事魏義良先生周可祥博士張蕾娣女士獨立非執行董事華風茂先生喻長遠博士梁曉燕女士監事李妍女士孫春麗女士姚佳維博士審計委員會梁曉燕女士（主席）華風茂先生喻長遠博士魏義良先生薪酬與考核委員會華風茂先生（主席）梁曉燕女士喻長遠博士倪健博士BOARD OF DIRECTORSExecutive DirectorsDr. Shen Yuelei (Chairman, chief executive officer and general manager)Dr. Ni JianDr. Zhang Haichao (Senior operation director of animal center)Non-executive DirectorsMr. Wei YiliangDr. Zhou KexiangMs. Zhang LeidiIndependent Non-executive DirectorsMr. Hua FengmaoDr. Yu ChangyuanMs. Liang XiaoyanSUPERVISORSMs. Li YanMs. Sun ChunliDr. Yao JiaweiAUDIT COMMITTEEMs. Liang Xiaoyan (Chairman)Mr. Hua FengmaoDr. Yu ChangyuanMr. Wei YiliangREMUNERATION AND EVALUATION COMMITTEEMr. Hua Fengmao (Chairman)Ms. Liang XiaoyanDr. Yu ChangyuanDr. Ni Jian 4Biocytogen Pharmaceuticals (Beijing) Co., Ltd. Interim Report 2023公司資料Corporate InformationNOMINATION COMMITTEEDr. Yu Changyuan (Chairman)Mr. Hua FengmaoMs. Liang XiaoyanDr. Shen YueleiSTRATEGY DEVELOPMENT COMMITTEEDr. Shen Yuelei (Chairman)Dr. Zhou KexiangMr. Wei YiliangMs. Zhang LeidiJOINT COMPANY SECRETARIESMr. Wang YongliangMs. Au Wai Ching (associate member of The Hong Kong Chartered Governance Institute and The Chartered Governance Institute in the United Kingdom)AUTHORIZED REPRESENTATIVESDr. Shen YueleiMs. Au Wai ChingAUDITORKPMGCertified Public AccountantsPublic Interest Entity Auditor registered in accordance with the Accounting and Financial Reporting Council Ordinance8th Floor, Prince’s Building10 Chater RoadCentral, Hong Kong提名委員會喻長遠博士（主席）華風茂先生梁曉燕女士沈月雷博士戰略發展委員會沈月雷博士（主席）周可祥博士魏義良先生張蕾娣女士聯席公司秘書王永亮先生區慧晶女士 （香港公司治理公會及英國 特許公司治理公會會員）授權代表沈月雷博士區慧晶女士核數師畢馬威會計師事務所執業會計師於《會計及財務匯報局條例》下的 註冊公眾利益實體核數師香港中環遮打道10號太子大廈8樓 55百奧賽圖(北京)醫藥科技股份有限公司 二零二三年中期報告公司資料Corporate Information合規顧問國泰君安融資有限公司香港皇后大道中181號新紀元廣場低座27樓H股股份過戶登記處卓佳證券登記有限公司香港夏愨道16號遠東金融中心17樓有關香港法例的法律顧問達維律師事務所香港遮打道3A號香港會所大廈10樓主要往來銀行中國建設銀行北京經濟技術開發區支行中國北京市大興區景園北街2號中國招商銀行北京亦莊支行中國北京市大興區榮華中路8號院力寶廣場8號樓1層公司網站 http://www.biocytogen.com.cn投資者聯絡資料電話：+86 010-56967601傳真：+86 010-56967666-8067郵件：ir@bbctg.com.cnCOMPLIANCE ADVISORGuotai Junan Capital Limited27/F, Low BlockGrand Millennium Plaza181 Queen’s Road CentralHong KongH SHARE REGISTRARTricor Investor Services Limited17/F, Far East Finance Centre16 Harcourt RoadHong KongLEGAL ADVISERS TO HONG KONG LAWDavis Polk & Wardwell10th Floor, The Hong Kong Club Building3A Chater Road, Hong KongPRINCIPAL BANKSChina Construction Bank Beijing Economic and Technological Development Zone Sub-branchNo. 2, Jingyuan North StreetDaxing DistrictBeijing, PRCChina Merchants Bank, Beijing Yizhuang Sub-branch1/F, Building 8, Libao PlazaNo. 8 Ronghua Middle RoadDaxing DistrictBeijing, PRCCOMPANY WEBSITEhttp://www.biocytogen.com.cnCONTACT INFORMATION FOR INVESTORSTel.: +86 010-56967601Fax: +86 010-56967666-8067Email: ir@bbctg.com.cn 6Biocytogen Pharmaceuticals (Beijing) Co., Ltd. Interim Report 2023財務概要Financial Summary截至2023年6月30日止六個月截至2022年6月30日止六個月同比變動Six months ended June 30, 2023Six months ended June 30, 2022 Period-to-period change 人民幣千元人民幣千元RMB’000RMB’000%（未經審核）（未經審核）(Unaudited)(Unaudited) 收益Revenue326,836229,13142.6毛利Gross profit235,364166,97041.0除稅前虧損Loss before taxation(189,389)(272,593)(30.5)期內虧損Loss for the period(189,809)(272,593)(30.4)本公司權益股東 應佔期內虧損Loss for the period attributable to equity shareholders of the Company(189,808)(272,385)(